✦ LIBER ✦

Effects of prucalopride (PRU) on colonic transit in patients (PTS) with chronic constipation (CC)

✍ Scribed by Sloots, C.E.J.; Poen, A.C.; Felt-Bersma, R.J.F.; Kerstens, Rene; Stevens, Marian; van Oene, J.C.; Meuwissen, S.G.M.

Book ID: 122872180
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 198 KB
Volume: 118
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(00)85531-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prucalopride (PRU) improves colonic tran

Prucalopride (PRU) improves colonic transit and stool frequency in patients (PTS) with slow and normal transit constipation

✍ Emmanuel, Anton V.; Nicholls, Tanya; Roy, Amanda J.; Antonelli, Kaye; Kamm, Mich 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Prucalopride (PRU) significantly improve

Prucalopride (PRU) significantly improves patient (PT) quality of life (QOL) and satisfaction level in chronic constipation (CC)

✍ Patrick Marquis; John F. Johanson; Philip B. Miner; Mary Ann Wojcik; Keith Karch 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Prucalopride (PRU) is safe and generally

Prucalopride (PRU) is safe and generally well tolerated in elderly patients with chronic constipation (CC)

✍ Alan Joslyn; Marita Stevens; Martine De Pauw; Rene Kerstens 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 43 KB

Prucalopride (PRU) improves bowel moveme

Prucalopride (PRU) improves bowel movement (BM)frequency and symptoms (SX) in patients (PTS) with chronic constipation (CC): Results of two doubleblind, placebo-controlled trials

✍ John F. Johanson; Philip B. Miner; Henry P. Parkman; Mary Ann Wojcik; Rena Lambe 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Prucalopride Improves Bowel Function and

Prucalopride Improves Bowel Function and Colonic Transit Time in Patients With Chronic Constipation: An Integrated Analysis

✍ Emmanuel, Anton; Cools, Marina; Vandeplassche, Lieve; Kerstens, René 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 278 KB

## Objectives: Constipation is often characterized by slow colonic transit, but the relationship between colonic transit time (CTT) and symptoms is unclear. The aims of this study were to investigate the effect of prucalopride, a 5-hydroxytryptamine receptor-4 agonist, on CTT and assess the relatio

Reproducibility of colonic transit study

Reproducibility of colonic transit study in patients with chronic constipation

✍ Young-Soo Nam; Alon J. Pikarsky; Steven D. Wexner; Jay J. Singh; Eric G. Weiss; 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 1007 KB